ACEIs, ANG 2 receptor antagonists and Renin Inhibitors Flashcards
Goal of antihypertensive therapy
reduce cardiovascular/renal morbidity and mortality
e.g. MI & strokes & damage to kidneys
Drugs used to treat hypertension
1) Agents affecting RAAS
- ACEIs
- ANG 2 antagonists
2) Thiazide diuretics (used alongside 1)
3) Calcium Channel Blockers (BAME population)
4) Beta adrenoreceptor antagonists - last choice
AT1 receptor
Gq receptor in smooth muscle
ANG II binds to receptor - causes hypertension by =
Vasoconstriction of afferent arterioles
Reduces synthesis of NO - vasodilator
Stimulates the release of aldosterone - Na+ and water reabsorption
Receptor action =
1) IP3 acts on sarcoplasmic reticulum to release Ca2+ - increases cardiac inotropy + stroke volume - O2 demand of respiring skeletal muscle
2) results in normal ( can happen in pathology too) remodelling of cardiac muscle = increased physiological demand
MOA of ACE inhibitors
PRILS
Competively antagonise ACE enzyme - stop conversion of ANG 1 to ANG II
Reduction of ANG II stops receptor activation in tissues
- reduces vascular tone
- increased production of bradykinin - contributes to vasodilation via increased NO/ Na+ excretion + inflammation of tissues
- decreases aldestrone release + sodium reabsorption
MOA of ANG II receptor antagonists
SARTANS
Competively antagonise the AT1 receptor to stop ANGII from binding
- block receptors in vasculature/adrenal/neuronal tissues
Reduction of ANG II =
- reduced vascular resistance
- decreased aldosterone release + sodium reabsorption
- decreased sympathetic activity - decreased cardiac output
MOA of renin inhibitor
Competitive antagonist of enzyme renin - stops conversion of angiotension to angiotension 1
- reduces vascular tone
- increases production of bradykinin
- decreases aldestreone release + Na+ reabsorption
Side effects of Ace Inhibitors
Dry cough - most common - caused by increased bradykinins - bronchospasm
Hyperkalemia - decreased aldestrone = K+ retention -> can cause renal failure
Skin rash
Hypotension - all vasculature is relaxed
Contraindications
- pregnancy
- renal artery stenosis
- renal disease - drugs may cause reduction in renal function
Side Effects of ANG II antagonists
Hyperkalemia
Hypotension
Allergic reactions - rare but serious
Contraindications Pregnancy Renal artery stenosis Renal disease Severe hepatic imparement - drug is metabolised by the liver
Caution
Breast feeding
Mild to moderate hepatic imparement
Elderly with postural hypotension/hyperkalaemia
Side Effects of Renin Inhibitors
Diarrhoea - dehydration!
Cough - less often than ACEis
Subject to drug interactions - metabolised by CYP3A4 - grapefruit
Contraindictaions
do not combine with ACEis/ARBs
pregnancy
Hypotension side effect
Augmented (extension of mechanism of action) adverse effect - especially when first used/when used with diurectics
Pharmacokinetics of ACEis
Administration: oral - Enalaprilat = IV (active metabolite)
- given as a prodrug - active forms are polar/poorly absorbed from the gut
Absorption: good and rapid - absorbed by gut wall
Metabolism: all prodrugs require hepatic metabolism
- active = “prilat”
Execretion = Kidneys except for fosinopril
Pharmacokinetics of ARBS
Candesartan - prodrug
Losartan - parent drug
Valsartan - parent drug
Administration: oral
Metabolism: Candesartan and Losartan - partially metabolised in liver to active metabolites
Excretion: Valsartan - unchanged as parent drug in bile
Canesartan/Losartan - excreted by kidney = more polar
ACE inhibitors in heart failure
Decrease in ANG II = vasodilation and decreased TPR
Protective effect - decreases futher hypertrophy in cardiac muscle in ventricles
Cardiac output becomes sufficient for perfusion - CO X TPR = BP
Impared diastolic filling
- impared myocardial relaxation
- increased stiffness in the ventricular wall
- decreased left ventricular compliance
Hypertension - heart failure
- increased wall stress stimulates myocyte hypertrophy + ventricular hypertrophy CARDIAC - decreased SV and CO - increased ED pressure VASCULAR - increased systemic resistance - increased afterload and TPR -decreased arterial pressure -decreased venous compliance -increased venous pressure -increased blood volume